We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PNR icon
776
Pentair
PNR
$11B
$11.6M 0.02%
311,648
+30,496
+11% +$1.16M
RCA
777
DELISTED
Ready Capital Corporation 7.00% Convertible Senior Notes due 2023
RCA
$11.6M 0.02%
433,175
+14,490
+3% +$385K
FTC icon
778
First Trust Large Cap Growth AlphaDEX Fund
FTC
$1.38B
$11.6M 0.02%
164,666
-1,042
-0.6% -$71.1K
TTC icon
779
Toro Company
TTC
$9.49B
$11.6M 0.02%
173,016
+168
+0.1% +$11.8K
HLT icon
780
Hilton Worldwide
HLT
$71.5B
$11.6M 0.02%
118,193
+44,505
+60% +$4.04M
FANG icon
781
Diamondback Energy
FANG
$52.7B
$11.5M 0.02%
105,927
-4,035
-4% -$421K
RFDI icon
782
First Trust RiverFront Dynamic Developed International ETF
RFDI
$168M
$11.5M 0.02%
203,051
-923
-0.5% -$52.2K
DOC icon
783
Healthpeak Properties
DOC
$14.8B
$11.5M 0.02%
360,065
+12,763
+4% +$397K
SPYM
784
State Street SPDR Portfolio S&P 500 ETF
SPYM
$168B
$11.5M 0.02%
331,784
+66,432
+25% +$2.25M
NMRK icon
785
Newmark Group
NMRK
$2.63B
$11.4M 0.02%
1,274,995
-123,292
-9% -$1.04M
XLRE icon
786
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.59B
$11.4M 0.02%
311,304
+119,512
+62% +$4.37M
OZK icon
787
Bank OZK
OZK
$5.61B
$11.3M 0.02%
376,846
-43,022
-10% -$1.33M
BURL icon
788
Burlington
BURL
$23.2B
$11.2M 0.02%
65,942
-23,387
-26% -$3.82M
WAB icon
789
Wabtec
WAB
$49.3B
$11.2M 0.02%
156,336
+65,302
+72% +$4.63M
MNA icon
790
IQ ARB Merger Arbitrage ETF
MNA
$253M
$11.2M 0.02%
354,894
-325,219
-48% -$10.3M
XPO icon
791
XPO
XPO
$23.7B
$11.2M 0.02%
558,380
-72,727
-12% -$1.48M
BST icon
792
BlackRock Science and Technology Trust
BST
$1.69B
$11.1M 0.02%
348,971
+9,444
+3% +$306K
MKSI icon
793
MKS Inc
MKSI
$20.6B
$11.1M 0.02%
142,955
+7,442
+5% +$629K
DOX icon
794
Amdocs
DOX
$6.22B
$11.1M 0.02%
179,023
+32,853
+22% +$1.9M
VEEV icon
795
Veeva Systems
VEEV
$37.4B
$11.1M 0.02%
68,505
+9,924
+17% +$1.45M
LFUS icon
796
Littelfuse
LFUS
$11.6B
$11.1M 0.02%
62,584
+477
+0.8% +$86.5K
HIG icon
797
Hartford Financial Services
HIG
$39.3B
$11.1M 0.02%
198,369
-27,060
-12% -$1.43M
FXO icon
798
First Trust Financials AlphaDEX Fund
FXO
$1.14B
$11M 0.02%
348,592
-70,591
-17% -$2.2M
IEX icon
799
IDEX
IEX
$17.3B
$11M 0.02%
64,003
-3,162
-5% -$497K
POST icon
800
Post Holdings
POST
$3.57B
$11M 0.02%
161,826
-5,252
-3% -$369K

Similar funds

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.